>AT2G32390.1 | ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel
MILSLEERPNLRLWRPLKTLMLTRVSSGAPSLILSSRTLIAVDLLAPWELMENKVVAAIG
PQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQNDYFQMNAITDFVSYF
RWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGADNSSISDLLASVNLMES
RIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSMEPLDPRALDLLQGVVA
FRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSVWLVARALDVFFSQGNT
VTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLTGQIEFNSEKNRINPAY
DILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRLNEIIWPGEVIKPPRGW
VFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAIQLLPYPVPRTYILYGD
GKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIESGLVVVAPVKGAKSSP
WSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQIITVFWFSFSTMFFSH
RENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRIEGMDTLIASNEPIGVQ
DGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAAIVDELPYIKALLSNSN
CKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEKIRKKWLTYDHECTMQI
SDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRPEESDEVQARSEEAGSS
RGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAENSQSKDHETPQ*
>AT2G32390.1 | ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel
MILSLEERPNLRLWRPLKTLMLTRVSSGAPSLILSSRTLIAVDLLAPWELMENKVVAAIG
PQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQNDYFQMNAITDFVSYF
RWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGADNSSISDLLASVNLMES
RIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSMEPLDPRALDLLQGVVA
FRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSVWLVARALDVFFSQGNT
VTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLTGQIEFNSEKNRINPAY
DILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRLNEIIWPGEVIKPPRGW
VFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAIQLLPYPVPRTYILYGD
GKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIESGLVVVAPVKGAKSSP
WSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQIITVFWFSFSTMFFSH
RENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRIEGMDTLIASNEPIGVQ
DGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAAIVDELPYIKALLSNSN
CKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEKIRKKWLTYDHECTMQI
SDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRPEESDEVQARSEEAGSS
RGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAENSQSKDHETPQ*
>AT2G32390.2 | ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel
MGALQLMENKVVAAIGPQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQ
NDYFQMNAITDFVSYFRWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGAD
NSSISDLLASVNLMESRIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSM
EPLDPRALDLLQGVVAFRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSV
WLVARALDVFFSQGNTVTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLT
GQIEFNSEKNRINPAYDILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRL
NEIIWPGEVIKPPRGWVFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAI
QLLPYPVPRTYILYGDGKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIE
SGLVVVAPVKGAKSSPWSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQ
IITVFWFSFSTMFFSHRENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRI
EGMDTLIASNEPIGVQDGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAA
IVDELPYIKALLSNSNCKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEK
IRKKWLTYDHECTMQISDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRP
EESDEVQARSEEAGSSRGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAE
NSQSKDHETPQ*
>AT2G32390.2 | ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel
MGALQLMENKVVAAIGPQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQ
NDYFQMNAITDFVSYFRWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGAD
NSSISDLLASVNLMESRIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSM
EPLDPRALDLLQGVVAFRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSV
WLVARALDVFFSQGNTVTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLT
GQIEFNSEKNRINPAYDILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRL
NEIIWPGEVIKPPRGWVFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAI
QLLPYPVPRTYILYGDGKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIE
SGLVVVAPVKGAKSSPWSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQ
IITVFWFSFSTMFFSHRENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRI
EGMDTLIASNEPIGVQDGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAA
IVDELPYIKALLSNSNCKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEK
IRKKWLTYDHECTMQISDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRP
EESDEVQARSEEAGSSRGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAE
NSQSKDHETPQ*
>AT5G51350.1 | leucine-rich repeat transmembrane protein kinase putative
MASSKHNKLCSFFYLCLFLTLVAAAEPQTESLLTLKSQLTDNFNSLKDWFINTPEVSDNL
VACCSWSGVRCNQNSTSVVSVDLSSKNLAGSLSGKEFLVFTELLELNISDNSFSGEFPAE
IFFNMTNLRSLDISRNNFSGRFPDGNGGDSSLKNLIFLDALSNSFSGPLPIHLSQLENLK
VLNLAGSYFTGSIPSQYGSFKNLEFLHLGGNLLSGHIPQELGNLTTLTHMEIGYNSYEGV
IPWEIGYMSELKYLDIAGANLSGFLPKHFSNLTKLESLFLFRNHLSREIPWELGEITSLV
NLDLSDNHISGTIPESFSGLKNLRLLNLMFNEMSGTLPEVIAQLPSLDTLFIWNNYFSGS
LPKSLGMNSKLRWVDVSTNSFQGEIPQGICSRGVLFKLILFSNNFTGTLSPSLSNCSTLV
RIRLEDNSFSGVIPFSFSEIPDISYIDLSRNKLTGGIPLDISKATKLDYFNISNNPELGG
KLPPHIWSAPSLQNFSASSCSISGGLPVFESCKSITVIELSNNNISGMLTPTVSTCGSLK
KMDLSHNNLRGAIPSDKVFQSMGKHAYESNANLCGLPLKSCSAYSSRKLVSVLVACLVSI
LLMVVAALALYYIRQRSQGQWKMVSFAGLPHFTADDVLRSFGSPEPSEAVPASVSKAVLP
TGITVIVRKIELHDKKKSVVLNVLTQMGNARHVNLVRLLGFCYNNHLVYVLYDNNLHTGT
TLAEKMKTKKKDWQTKKRIITGVAKGLCFLHHECLPAIPHGDVKSSNILFDDDKIEPCLG
EFGFKYMLHLNTDQMNDVIRVEKQKDVYNFGQLILEILTNGKLMNAGGLMIQNKPKDGLL
REVYTENEVSSSDFKQGEVKRVVEVALLCIRSDQSDRPCMEDALRLLSEAENRFK*
>AT2G24710.1 | ATGLR23 intracellular ligand-gated ion channel
MRTEKLFFCILLVFFFCLEFNRGQNNGKTLVDVGVVTDVDTSHSKVVMLCINMSISDFYS
SNPQFETRLVVNVGDSKSDVVGAAIAALDLIKNKQVKAILGPWTSMQAHFLIEIGQKSRV
PIVSYSATSPILTSLRSPYFLRATYEDSFQVQPIKAIIKLFGWREVVPVYIDNTFGEGIM
PRLTDALQDINVRIPYRSVIAINATDHEISVELLKMMNMPTRVFLVHMYYDLASRFFIKA
KELGLMEPGYVWILTNGVIDDLSLINETAVEAMEGVLGIKTYIPKSPDLEKFRSRWRSLF
PRVELSVYGLWAYDATTALAVAIEEAGTNNMTFSKVVDTGRNVSELEALGLSQFGPKLLQ
TLLTVQFRGLAGEFRFFRGQLQPSVFEIVNIINTGEKSIGFWKEGNGLVKKLDQQASSIS
ALSTWKDHLKHIVWPGEADSVPKGWQIPTKGKKLRIGVPKRTGYTDLVKVTRDPITNSTV
VTGFCIDFFEAVIRELPYDVSYEFIPFEKPDGKTAGNYNDLVYQVYLGRYDAVVGDTTIL
VNRSSYVDFTFPFIKSGVGLIVEMTDPVKRDYILFMKPLSWKLWLTSFISFFLVGCTVWV
LEYKRNPDFSGPPRFQASTICWFAFSTMVFAPRERVFSFWARALVIAWYFLVLVLTQSYT
ASLASLLTSQKLNPTITSMSSLLEKGETVGYQRTSFILGKLKERGFPQSSLVPFDTAEEC
DELLSKGPKKGGVSGAFLEIPYLRLFLGQFCNTYKMVEEPFNVDGFGFVFPIGSPLVADV
SRAILKVAESPKAMELERAWFKKKEQSCPDPITNPDPNPSFTSRQLDIDSFLFLFVGVLL
VCVMALGNFTYCFLAKDQVSYLDKVEMSPCSSSQQMPVKRKTQLNMSQVHDQDSL*
>AT1G77460.1 | binding
MLKAFLPGTQEEETLSSLQSGKVDAKMEMDDPEKAMATVAQLIEQLHAKTSSPQDKELTT
ARLLGIAKGKREARRLIGSYGQAMPLFISMLRNGTTLAKVNVASILCVLCKDKDLRLKVL
LGGCIPPLLSVLKSGTMETRKAAAEAIYEVSSAGISNDHIGMKIFITEGVVPTLWDQLSL
KGNQDKVVEGYVTGALRNLCGVDDGYWRLTLEGSGVDIVVSLLSSDNPNSQANAASLLAR
LVLSFCDSIQKILNSGVVKSLIQLLEQKNDINVRASAADALEALSANSDEAKKCVKDAGG
VHALIEAIVAPSKECMQGKHGQSLQEHATGALANVFGGMRHLIIYLGQVSQSPRLTEPIG
DVIGALAYALMIFKQPESSENIFDPSVIESILVKLLKPRDTKLIQERILEAMASLYGNSS
LSCYLDDAEAKRVLIALITMASADVRERLIICLSGLCHDKVGIWEAIGKREGIQLFISFL
GLSSEQHQEYAVEMLKILTAQVDDSKWAVTAAGGIPPLVQLLETGSQKAKEDAACILWNL
CCHSEEIRDCVERAGGIPAFLWLLKTGGPNSQETSAKTLVKLVHTADPATINQLLALLLG
DDPTSKIQVIEVLGHVLSKASQEDLVHRGCAANKGLRSLVESLTSSREETKEHTASVLAD
LFSSRQDICGHLATDDIINPWIKLLTNNTQNVAKQVARALDALSRPVKNNNNKKKSYIAE
GDIKSLIKLAKNSSIESAENAVSALANLLSDPDIAAEALAEDVVSAFTRILADGSPEGKR
NASRALHQLLKNFPVCDVLKGSAQCRFAILSLVDSLKSIDVDSADAFNILEVVALLAKTK
SGVNFSYPPWIALAEVPSSLETLVQCLAEGHTLVQDKAIEVLSRLCSDQQFLLSELIVSR
PKSMLVLADRIVNASSLEVRVGSTALLLCAAKEKKQLITETLDQSGFLKLLLHALVDMIK
HNSTSFSLETEVQTPKGFLEKNVFQDTGSFYFPDPAKILGGTVALWLLCILTSVDAKSKV
IVMEAGGLEVLVGKLARYTSSAQAEFEDTEGIWISALLLAIMFQDDNVSFSSTTMRIIPT
LAVLLGSDELIDRYFAAHAMASLVCTRNRGINLTIANSGAVSGIINLLGYVESEILNLVA
LANEFSLVKEPDQVILQHLFEIEDVRLGSTARKSIPLLVDLLRPIPDRPGAPQFAVQILI
RIADGSDTNKLLMAEAGAVEALTKYLSLSPQDSTEYAISELLRVLFSNHELRQNEMALSS
LNQLIAVLRLGSRSARYSAAGALNELFDAENIRNSEIACQAVQPLMDILGSVSESEQEVA
LSALIKLSSGNTSNTALLIDVEGSLLENVIKILSSATASEELKINAARLCSVVFSNKNIR
TSASASGCMKPLITLMQSERSAAVEAAVFAIKILLDDEQHLELAAAHNIQELLVGLVSGK
NYVIIEASLSALIKLGKDRVPRKLDMVEAGIIERCLELLPGASSSLCSAVVELFRILTNS
GVIARRPDVAKTVEPLFAVLLRSDLTLWGQHSALQALVNILEKQQTLEAFSFTPSEAIVP
LISFLESSSQAIQQLGAELLSHFLTMEDFQQDITTQSAVVPLVRLAGIGILSLQETAIKA
LEKISASWPKAVLDAEGIFELSKVILQEDPQPPLDLWESAAFVLSNILQYDAECFFRVEL
PVLVKLLFSTIESTVLLALKALMLHEKNDASSTVQMAELGAIDALLDLLRSHQCEEESGS
LLEVIFNNPRVRELKLCKYAIAPLSQYLLDPHTRSEPGRLLAALALGDLSQHEGLSRSSG
SVSACRALISVLEEQPTEEMKVVAICALQNFVMNSRTNRRAVAEAGGVLLIQELLLSCNP
EVSGQAALMVKFLFSNHTLQEYVSNELIRSLTAALERGLWSTATINIEVLRTLNVIFSNF
PKLRASEAATFCIPHLVGALKSGVEDVQGLVLDILYLLRHSWTNMSIDVAKSQAMIAAEA
IPVLQMLMKTCPPRFHDKADSLLHCLPGCLTVNVMRANNLKQSMATTNAFCQLTIGNCPP
RQTKVVSNSTTPEWKEGFTWAFDVPPKGQKLHIICKSKSTFGKTTLGRVTIQIDKVVTEG
EYSGSLSLNHENSKDASSRSLDIEIAWSNRTTDETH*
>AT3G54980.1 | pentatricopeptide (PPR) repeat-containing protein
MRSLLVFRKIPSRIRLRNLRNNKPFCSQSQFPKESENPSQEQRLLVYGSTSEENPVTSKV
SLLSAKPEQKDDASVIDVLLNRRNNPEAALRFYNWARPWRGSFEDGDVFWVLIHILVSSP
ETYGRASDLLIRYVSTSNPTPMASVLVSKLVDSAKSFGFEVNSRAFNYLLNAYSKDRQTD
HAVDIVNQMLELDVIPFFPYVNRTLSALVQRNSLTEAKELYSRMVAIGVDGDNVTTQLLM
RASLREEKPAEALEVLSRAIERGAEPDSLLYSLAVQACCKTLDLAMANSLLREMKEKKLC
VPSQETYTSVILASVKQGNMDDAIRLKDEMLSDGISMNVVAATSLITGHCKNNDLVSALV
LFDKMEKEGPSPNSVTFSVLIEWFRKNGEMEKALEFYKKMEVLGLTPSVFHVHTIIQGWL
KGQKHEEALKLFDESFETGLANVFVCNTILSWLCKQGKTDEATELLSKMESRGIGPNVVS
YNNVMLGHCRQKNMDLARIVFSNILEKGLKPNNYTYSILIDGCFRNHDEQNALEVVNHMT
SSNIEVNGVVYQTIINGLCKVGQTSKARELLANMIEEKRLCVSCMSYNSIIDGFFKEGEM
DSAVAAYEEMCGNGISPNVITYTSLMNGLCKNNRMDQALEMRDEMKNKGVKLDIPAYGAL
IDGFCKRSNMESASALFSELLEEGLNPSQPIYNSLISGFRNLGNMVAALDLYKKMLKDGL
RCDLGTYTTLIDGLLKDGNLILASELYTEMQAVGLVPDEIIYTVIVNGLSKKGQFVKVVK
MFEEMKKNNVTPNVLIYNAVIAGHYREGNLDEAFRLHDEMLDKGILPDGATFDILVSGQV
GNLQPVRAASL*
>AT1G74600.1 | pentatricopeptide (PPR) repeat-containing protein
MNCLANESLNSLKISPFSTSRLLSSVTNFRNQLSFSSKDSSSSSAPFNPFRFFNDQSNSR
LCNLRTTKILQAHLLRRYLLPFDVFLTKSLLSWYSNSGSMADAAKLFDTIPQPDVVSCNI
MISGYKQHRLFEESLRFFSKMHFLGFEANEISYGSVISACSALQAPLFSELVCCHTIKMG
YFFYEVVESALIDVFSKNLRFEDAYKVFRDSLSANVYCWNTIIAGALRNQNYGAVFDLFH
EMCVGFQKPDSYTYSSVLAACASLEKLRFGKVVQARVIKCGAEDVFVCTAIVDLYAKCGH
MAEAMEVFSRIPNPSVVSWTVMLSGYTKSNDAFSALEIFKEMRHSGVEINNCTVTSVISA
CGRPSMVCEASQVHAWVFKSGFYLDSSVAAALISMYSKSGDIDLSEQVFEDLDDIQRQNI
VNVMITSFSQSKKPGKAIRLFTRMLQEGLRTDEFSVCSLLSVLDCLNLGKQVHGYTLKSG
LVLDLTVGSSLFTLYSKCGSLEESYKLFQGIPFKDNACWASMISGFNEYGYLREAIGLFS
EMLDDGTSPDESTLAAVLTVCSSHPSLPRGKEIHGYTLRAGIDKGMDLGSALVNMYSKCG
SLKLARQVYDRLPELDPVSCSSLISGYSQHGLIQDGFLLFRDMVMSGFTMDSFAISSILK
AAALSDESSLGAQVHAYITKIGLCTEPSVGSSLLTMYSKFGSIDDCCKAFSQINGPDLIA
WTALIASYAQHGKANEALQVYNLMKEKGFKPDKVTFVGVLSACSHGGLVEESYFHLNSMV
KDYGIEPENRHYVCMVDALGRSGRLREAESFINNMHIKPDALVWGTLLAACKIHGEVELG
KVAAKKAIELEPSDAGAYISLSNILAEVGEWDEVEETRKLMKGTGVQKEPGWSSV*